We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




In Vitro Technique Details Cancer Cell Attachment and Spread

By LabMedica International staff writers
Posted on 02 Oct 2018
A team of Japanese cell biologists described the development of a simple live-tumor in vitro imaging technique that enabled the study of the processes involved in the growth and spread of pancreatic cancer.

Investigators at Hokkaido University (Japan) reported in the September 19, 2018, online edition of the journal Scientific Reports that they had invented a new cell culture substrate comprising a coated nanoscale glass slide with etched islands of 30 micrometers in diameter, which allowed dynamic visualization of pancreatic ductal adenocarcinoma (PDAC) microtumors.

The investigators reported that when PDAC cells were cultured on the etched slides overnight, the cells self-organized into non-spheroidal microtumors that were anchored to the surface through cell-in-cell invasion (entosis). More...
Using a time-lapse imaging system, they found that PDAC microtumors actively stretched to catch dead cell debris via filipodia (hair-like projections similar to those used for locomotion by some amoebas) and lamellipodia (cytoskeletal actin projections on the mobile edge of the cell).

The etched microplate method enabled visualization of live tumor dynamics; the microtumors endocytosed debris-derived surface nucleosides directly into vacuoles and then accumulated dead cell-derived phosphatidylserine (PS) on their surfaces (resulting in PS externalization, a cause of cancer immune evasion).

"Cancer studies so far either use cell cultures in which cancer cells do not necessarily behave naturally, or tissue samples that do not allow live observation. So there is a big gap in our knowledge of how cancer cells actually behave," said first author Dr. Yukiko Miyatake, assistant professor of pathology at Hokkaido University. "I hope this easy and low-cost technique will find widespread adoption. If the discoveries made during these first observations are physiologically or pathologically relevant phenomena, many more new hints may be gleaned for the development of more effective cancer treatment approaches."

Related Links:
Hokkaido University


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.